Juvaris BioTherapeutics (United States)

Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs

Christopher R. Behrens, Edward Ha, Lawrence Chinn et al. · Molecular Pharmaceutics · 2015 · 150 citations · Full text

Afford Adcs, Immunology, Immunotherapeutics +19

Processes for Constructing Homogeneous Antibody Drug Conjugates

David Y. Jackson · Organic Process Research & Development · 2016 · 76 citations

Medicinal Chemistry, Biochemistry, Homogeneous Adcs +11

Antitumor activity of an anti‐<scp>CD</scp>98 antibody

Gregory M. Hayes, Lawrence Chinn, Joseph M. Cantor et al. · International Journal of Cancer · 2014 · 69 citations · Full text

Antitumor Activity, Immunology, Care Carboplatin +17

Effect of a glucagon receptor antibody (REMD‐477) in type 1 diabetes: A randomized controlled trial

Jeremy Pettus, Dominic N. Reeds, Tricia Santos Cavaiola et al. · Diabetes Obesity and Metabolism · 2017 · 62 citations · Full text

Clinical Trial Reg, Metabolic Syndrome, Type 1 +13

Cationic lipid/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone®) increases antibody response, cellular immunity, and antigenically drifted protection

Marla Lay, Bernadette Callejo, Stella Chang et al. · Vaccine · 2009 · 52 citations · Full text

Vaccination, Mucosal Vaccination, Cross-protection +10